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Background: While it is known that elevated baseline intracardiac repolarization lability is
associated with the risk of fast ventricular tachycardia (FVT)/ventricular fibrillation (VF), the
effect of its longitudinal changes on the risk of FVT/VF is unknown.
Methods and Results: Near-field (NF) right ventricular (RV) intracardiac electrograms
(EGMs) were recorded every 3–6 months at rest in 248 patients with structural heart
disease [mean age 61.2 ± 13.3; 185(75%) male; 162(65.3%) ischemic cardiomyopathy]
and implanted cardioverter-defibrillator (ICD) or cardiac resynchronization therapy
defibrillator (CRT-D) [201 (81%) primary prevention]. Intracardiac beat-to-beat QT variability
index (QTVINF) was measured on NF RV EGM. During the first study phase (median 18
months), participants made on average 2.4 visits. Then remote follow-up was continued
for an additional median period of 3 years. Average QTVINF did not change during the first
year after ICD implantation (−0.342 ± 0.603 at baseline vs. −0.262 ± 0.552 at 6 months
vs. −0.334 ± 0.603 at 12 months); however, it decreased thereafter (−0.510 ± 0.603 at 18
months; P = 0.042). Adjusted population-averaged GEE model showed that the odds of
developing FVT/VF increased by 75% for each 1 unit increase in QTVINF. (OR 1.75 [95%CI
1.05–2.92]; P = 0.031). However, individual patient–specific QTVINF trends (increasing,
decreasing, flat) varied from patient to patient. For a given patient, the odds of developing
FVT/VF were not associated with increasing or decreasing QTVINF over time [OR 1.27;
(95%CI 0.05–30.10); P = 0.881].
Conclusion: While on average the odds of FVT/VF increased with an increase in QTVINF,
patient-specific longitudinal trends in QTVINF did not affect the odds of FVT/VF.
Keywords: intracardiac electrograms, repolarization lability, ventricular tachyarrhythmia, longitudinal analysis, QT
variability index
Augmented intracardiac repolarization lability predicts ventric-
ular arrhythmia (Haigney et al., 2004; Couderc et al., 2007;
Tereshchenko et al., 2009), sudden cardiac death (SCD) (Piccirillo
et al., 2007) and cardiovascular mortality (Tereshchenko et al.,
2012) in patients with structural heart disease and long QT
syndrome (Hinterseer et al., 2008). Underlying mechanisms of
increased repolarization lability are associated with arrhythmo-
genic substrate [scar, fibrosis, local heterogeneities in action
potential duration and morphology, cell-to-cell uncoupling,
stochastic gating of ion channels (Pueyo et al., 2011), and
increased sympathetic tone in the ventricles of the heart (Baumert
et al., 2011)]. It is known that arrhythmogenic substrate does
change over time. However, little is known about neither the rate
of changes in repolarization lability over 6–12–18 month period
nor the predictive value of these changes.
Dynamic time-dependent association between alternating
repolarization variability and cardiac death has been previ-
ously reported. The Alternans Before Cardioverter Defibrillator
(ABCD) Trial showed that baseline microvolt T-wave alter-
nans (TWA) was significantly associated with sustained ven-
tricular tachycardia (VT)/ ventricular fibrillation (VF) or SCD
at 6 months, but lost association at 12 months of follow-up
(Costantini et al., 2009). ABCD trial results brought up discus-
sion regarding the necessity for establishing the “expiration date”
for TWA results, and raised the question about possible utility of
repetitive TWA assessment. While elevated repolarization lability,
TWA and other non-invasive risk markers (including decreased
heart rate variability) have been found to be associated with life-
threatening VT/VF and SCD, none of them are routinely used for
risk stratification of primary prevention implantable cardioverter
defibrillator (ICD) (Tereshchenko and Berger, 2012). Repeated
measurement of risk markers might strengthen their predictive
value. However, studies of longitudinal changes in repolarization
lability are limited.
Earlier we showed that repolarization lability is present
throughout the myocardium (Tereshchenko et al., 2009). We
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demonstrated that the single baseline measurement of intracar-
diac QT variability index (QTVINF), was associated with fast ven-
tricular tachycardia (FVT)/VF during the subsequent 16 months
of follow-up. However, the effect of longitudinal changes in
intracardiac repolarization lability on the risk of FVT/VF is
unknown. The goal of the present study was to determine if
patients with increasing intracardiac QTVINF over time expe-
rience a greater probability of having FVT/VF than those with
decreasing or stable intracardiac QTVINF.
METHODS
The ICD-EGMs study (Tereshchenko et al., 2009) protocol was
approved by the Johns Hopkins University and the Washington
University Human Studies Committees and all participants gave
written informed consent before entering the study.
STUDY POPULATION
The ICD-EGMs study design (NCT00916435) was previously
described (Tereshchenko et al., 2009). Briefly, patients with struc-
tural heart disease of either sex older than 18 years were enrolled
in the study if they had a transvenous ICD or a cardiac resynchro-
nization therapy defibrillator (CRT-D) device implanted for pri-
mary or secondary prevention of SCD. In this study we included
only participants who (1) had ICD or CRT-D implanted 1 week
before enrollment, (2) made at least 2 consecutive office follow-
up visits during the first study phase (2005–2007), (3) had at
least 2 analyzable digital recordings of intracardiac EGMs at rest
that were at least 30 days apart, (4) had EGMs recorded in sinus
rhythm, with (5) identical type of ventricular activation [either
ventricular-sensed (VS), or ventricular-paced (VP)] at baseline
and at all follow-up visits.
RECORDING OF INTRACARDIAC EGMs AND FOLLOW-UP OF STUDY
PARTICIPANTS
Recording of intracardiac EGMs was performed at every office
follow-up visit (every 3–6 months) during the first 2 years of
the study (2005–2007). Patients were then followed remotely
via Carelink® and Latitude® during next 4 years (2007–2011).
Near-field (NF) and far-field (FF) RV intracardiac EGMs were
recorded at rest for 5–15min simultaneously with surface electro-
cardiogram (ECG) via ICD programmer as previously described
(Tereshchenko et al., 2009).
Duration of time periods between follow-up visits varied from
patient to patient, due to the observational nature of the study. In
order to standardize assessment of longitudinal changes in EGM
parameters, we categorized follow-up periods as the following. All
follow-up visits that occurred in a period of 1–6 months after the
baseline (Visit 1) were considered as Visit 2. Visit 3 EGM record-
ing was performed at any time in a period of 181–365 days after
baseline EGM recording. Visit 4 was performed during the 1st half
of the 2nd year of follow-up.
INTRACARDIAC REPOLARIZATION LABILITY ANALYSIS
Intracardiac repolarization lability was measured on NF RV
EGM as previously described (Tereshchenko et al., 2009) by
Berger’s method (Berger et al., 1997), using customized MATLAB
(MathWorks, Inc., Natick, MA) software. The R-wave peak
was automatically detected on NF EGM channel. Two investi-
gators (AG, JL) defined an intracardiac intervals template by
selecting the beginning and the end of major NF EGM deflec-
tion, and the end of the T wave. The algorithm then determined
how much the repolarization segment of each beat had to be
stretched or compressed to match the template. Appropriate
selection of fiducial points was verified by the third investigator
(LGT). Premature ventricular and atrial beats with one post-
ectopic sinus beat were excluded from the analysis. Recordings
with more than 15% of ectopic, or noise-distorted beats were
excluded.
ENDPOINTS
Appropriate ICD shocks for FVT/VF served as the endpoints
in this study. Programming of the ICD device was based on
clinical evaluation of the attending electrophysiologist. ICD inter-
rogation data was adjudicated by an endpoint committee com-
posed of 3 members. ICD therapy occurring for VT or VF was
classified as appropriate (Tereshchenko et al., 2009). FVT/VF
was defined as VT/VF with an average cycle length (CL) ≤
240ms. After the 1st FVT/VF event follow-up was continued,
and all subsequent sustained FVT/VF events with appropri-
ate ICD shocks were included in the analysis as the study
endpoints.
STATISTICAL ANALYSIS
The association of baseline clinical characteristics and ECG
parameters with the type of presenting rhythm was measured by
the χ2-tests and ANOVAor t-test, respectively, for categorical and
continuous variables with normal distribution. A test of equality
of medians or Wilcoxon rank-sum test was used in case the dis-
tribution of parameter was not normal. A P-value of <0.05 was
considered significant. Data analysis was performed using STATA
12.1 (StataCorp LP, College Station, TX).
As office visits were unequally spaced in time, QTVI vari-
ogram was explored, and follow-up time periods were equalized
with incremental 6 months-intervals. Possible effects of VP on
longitudinal QTVINF changes were explored in patients with dif-
ferent devices types (single-chamber ICD, dual-chamber ICD,
CRT-D), as well as in patients who predominantly (at least
99% of follow-up time and 100% of recorded EGM) had VS,
in comparison to VP rhythm. “Spaghetti” plots were examined
to study variations of QTVINF across time for each individ-
ual. Smoothed plots were used to explore group response of
QTVINF as a function of time, to study variations of QTVINF
across different individuals. Average changes in QTVINF per
6 months of follow-up were determined. Patterns of QTVINF
changes over time in patients with and without FVT/VF were
compared. Since repeated measures made on the same sub-
ject are correlated, within-person correlations matrix of QTVINF
across multiple visits was estimated, and the correlation struc-
ture was described. The correlation structure for the resid-
uals was explored after removing the mean trend effect. To
standardize QTVINF at each visit, we subtracted observations
in each category (each visit) by the mean for that visit and
then divided them by the standard deviation for that visit.
Further longitudinal regression analyses took into account the
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visit-to-visit QTVINF correlation structure to obtain valid infer-
ences.
We compared the association of FVT/VF events with pre-
ceding longitudinal QTVINF changes in an average study par-
ticipant (in the population-averaged model), and in specific
study subject (in the subject-specific model). Population-
averaged marginal model accounting for correlation struc-
ture [Generalized Estimating Equations (GEE) model] was
developed. Multivariate GEE model was used to determine
an association between a population-averaged longitudinal
QTVINF changes, and a subsequent outcome. FVT/VF events
with appropriate ICD shocks that occurred after respective
QTVINF measurements served as an outcome. GEE model
was adjusted by age, sex, race, left ventricular ejection frac-
tion (LVEF), New York Heart Association (NYHA) heart failure
class (dichotomized as NYHA = II), indication for ICD (pri-
mary or secondary prevention of SCD), type of cardiomyopathy
(ischemic or non-ischemic), history of revascularization proce-
dure (either PCI or CABG), type of implanted device(single-
chamber ICD, dual-chamber ICD, CRT-D), type of analyzed
rhythm (VS or VP), and use of class III anti-arrhythmic medi-
cations.
In order to determine the patient-specific association of lon-
gitudinal QTVINF changes with subsequent FVT/VF, we ran a
random intercept model for FVT/VF. We accounted for corre-
lation of the repeated QTVINF observations by including a ran-
dom intercept for each patient and control for patient’s QTVINF
(centered). Adequate fitting of the model was checked to ensure
that the specified quadrature has adequately approximated the
likelihood.
RESULTS
STUDY POPULATION
We analyzed the data of 248 study participants: 185 (74.6%)
men, 201 Whites (81%), mean age 61.2 ± 13.3 y. Clinical
characteristics of study participants are shown in Table 1.
We categorized study participants based on their presenting
rhythm during follow-up office visits. VS participants were
paced <1% during the study duration (Table 1) and were not
paced from ventricle(s) during study EGM recordings. Patients
who presented with a sinus rhythm, and were 100% VP dur-
ing the study EGM recordings, comprised VP group. Figure 1
shows representative examples of longitudinal changes in RR’
and QT variability in patients with and without ventricular
arrhythmia.
As expected, due to the differences in HF severity, CRT-D
patients had significantly higher mean heart rate as compared to
single-and dual-chamber ICD patients (Table 2). However, QT
interval on NF RV EGM (QTNF) was longer in patients with dual-
chamber ICDs as compared to those with single chamber ICDs
and CRT-Ds. There were no significant differences in heart rate
variance, QTNF variance, and QTVINF amongst patients with dif-
ferent device types, nor in patients with presenting VS vs. those
with VP sinus rhythm (Table 2).
Table 1 | Comparison of demographic and clinical characteristics of patients with single-, dual-chamber ICD, and CRT-D, and in patients with
sinus ventricular-sensed and ventricular-paced rhythm.
Single chamber Dual chamber CRT-D (n = 12) ANOVA P V-sensed V-paced P-value
ICD (n = 139) ICD (n = 97) (n = 195) (n = 53)
Age(SD), y 58.2 (13.0) 64.5 (13.3) 69.8 (7.5) 0.0001 60.3 (13.4) 64.5 (12.6) 0.036
Males, n(%) 101 (72.7) 74 (76.3) 10 (83.3) 0.636 145 (74.4) 40 (75.5) 0.869
African American, n(%) 35 (25.2) 10 (10.3) 2 (16.7) 0.016 40 (20.5) 7 (13.2) 0.229
CHF NYHA class = II, n(%) 92 (66.2) 52 (53.6) 12 (100.0) 0.003 118 (60.5) 38 (71.7) 0.135
Ischemic CM, n(%) 85 (61.2) 69 (28.9) 4 (33.3) 0.283 70 (35.9) 16 (30.2) 0.439
Primary prevention of SCD, n(%) 28 (20.1) 19 (19.6) 0 0.228 157 (80.5) 44 (83.0) 0.680
Presenting VP rhythm, n(%) 2 (1.4) 40 (41.2) 11 (91.7) <0.0001 – – –
Atrial pacing %, median(IQR) – 11.5 (0–76) 0 (0–0) <0.0001 16 (0–76) 1.5 (0–74) 0.328
Ventricular pacing %, median(IQR) 0 (0–0) 4.5 (0–29.5) 100 (98–100) <0.0001 0 (0–1) 16 (1–91) <0.0001
LVEF(SD), (%) 31.9 (12.2) 32.4 (11.3) 25.0 (12.4) 0.127 32.4 (12.1) 29.3 (11.2) 0.075
Diabetes mellitus Hx, n(%) 50 (36.0) 23 (24.0) 3 (25.0) 0.132 65 (33.5) 11 (20.8) 0.075
Hypertension Hx, n(%) 108 (77.7) 67 (69.8) 10 (83.3) 0.306 150 (77.3) 35 (66.0) 0.093
CABG or PTCA Hx, n(%) 65 (46.8) 51 (52.6) 7 (58.3) 0.561 94 (48.2) 29 (54.7) 0.400
History of AF, n(%) 32 (23.0) 43 (44.3) 7 (58.3) <0.0001 55 (28.2) 27 (50.9) 0.002
Beta blockers, n(%) 126 (90.7) 78 (80.4) 8 (72.7) 0.038 171 (87.7) 41 (78.9) 0.104
ACE-Inhibitors or ARBs, n(%) 111 (79.9) 78 (80.4) 11 (91.7) 0.609 155 (79.5) 45 (84.9) 0.376
Digitalis, n(%) 45 (32.4) 39 (40.2) 5 (45.5) 0.375 69 (35.4) 20 (38.5) 0.681
Statin, n(%) 97 (69.8) 68 (70.1) 8 (72.7) 0.979 137 (70.3) 36 (69.2) 0.886
Nitrates, n(%) 36 (26.1) 20 (20.6) 5 (45.5) 0.170 50 (25.8) 11 (21.2) 0.493
Aldosterone antagonists, n(%) 53 (38.1) 37 (38.1) 5 (45.4) 0.888 76 (39.0) 19 (36.5) 0.748
Antidepressants, n(%) 30 (21.6) 33 (34.0) 3 (27.3) 0.105 47 (24.1) 19 (36.5) 0.072
Class III antiarrhythmics, n(%) 24 (17.3) 33 (34.0) 5 (45.5) 0.004 42 (21.5) 20 (38.5) 0.012
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FIGURE 1 | Representative example of longitudinal changes in beat-to-beat intracardiac QT and RR’ variability in patient with (A) and without (B)
sustained FVT/VF and appropriate ICD shocks.
Table 2 | Comparison of all-visits averaged ECG parameters in patients with single-, dual-chamber ICD, and CRT-D, and in patients with sinus
ventricular-sensed and ventricular-paced rhythm.
Single chamber Dual chamber CRT-D (n = 24) ANOVA P V-sensed V-paced P-value
ICD (n = 332) ICD (n = 230) (n = 464) (n = 122)
Heart rate(SD), bpm 74.2 (14.5) 71.1 (13.3) 78 (17.5) 0.009 72.8 (14.3) 74.5 (14.2) 0.231
QT interval(SD), ms 469 (116) 496 (110) 478 (180) 0.030 479 (116) 487 (123) 0.477
Heart rate variance,
median(IQR), ms2
40.2 (7.9–91.5) 47.1 (12.8–99.4) 45.7 (14.0–117.7) 0.549 41.0 (9.1–93.2) 48.6 (13.0–106.7) 0.209
QT variance,
median(IQR), ms2
748 (122–1693) 729 (167–1704) 556 (269–1190) 0.699 726 (130–1699) 715 (196–1678) 0.617
QTVI(SD) −0.307 (0.548) −0.402 (0.648) −0.293 (0.641) 0.163 −0.344 (0.570) −0.345 (0.679) 0.983
VENTRICULAR TACHYARRHYTHMIA DURING FOLLOW-UP
During the first study phase participants made on average 2.4 vis-
its. FVT/VF events with appropriate ICD shocks were diagnosed
in 26 (10.5%) patients. Multiple FVT/VF during follow-up were
observed in 20 (77%) out of 26 patients, frequently in clusters.
Baseline clinical characteristics in patients with or without
FVT/VF during follow-up did not differ (Table 3). Importantly,
QTVINF was the only ECG parameter that differentiated patients
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Table 3 | Comparison of baseline clinical and demographic
characteristics in patients with and without FVT/VF during follow-up.
No FVT/VF FVT/VF P-value
(n = 222) (n = 26)
Age(SD), y 61.9 (12.8) 55.3 (16.6) 0.058
Males, n(%) 165 (74.3) 20 (76.9) 0.773
African American, n(%) 43 (19.4) 4 (15.4) 0.624
CHF NYHA class = II, n(%) 138 (62.3) 18 (69.2) 0.480
Ischemic CM with MI history,
n(%)
145 (65.3) 17 (65.4) 0.994
Primary prevention of SCD,
n(%)
180 (81.1) 21 (80.8) 0.969
Single-chamber ICD, n(%) 124 (55.9) 15 (57.7) 0.963
Dual-chamber ICD, n(%) 87 (39.2) 10 (38.5) 0.963
Bi-Ventricular ICD, n(%) 11 (5.0) 1 (3.9) 0.963
Atrial pacing1 %,
median(IQR)
9.5 (0–71.5) 32 (1–92) 0.053
Ventricular pacing2 %,
median(IQR)
0 (0–3) 0 (0–0) 0.152
LVEF(SD), (%) 31.7 (11.8) 32.5 (13.5) 0.777
Diabetes mellitus, n(%) 68 (30.8) 8 (30.8) 1.00
Hypertension, n(%) 165 (74.7) 20 (76.9) 0.901
CABG or PTCA, n(%) 111 (50.0) 12 (46.2) 0.711
History of AF, n(%) 74 (33.3) 8 (30.8) 0.793
Beta blockers, n(%) 192 (86.9) 20 (76.9) 0.169
ACE-Inhibitors or ARBs, n(%) 181 (81.5) 19 (73.1) 0.302
Digitalis. n(%) 76 (34.4) 13 (50.0) 0.117
Statin, n(%) 156 (70.6) 17 (65.4) 0.584
Nitrates, n(%) 55 (25.0) 6 (23.1) 0.830
Aldosterone antagonists,
n(%)
86 (38.9) 9 (34.6) 0.670
Antidepressants, n(%) 58 (26.2) 8 (30.8) 0.622
Class III antiarrhythmic
medication, n(%)
55 (24.9) 7 (26.9) 0.821
1Percentage of atrial pacing during study phase 1 (counters data) in patients
with dual-chamber ICD or CRT-D; 2percentage of ventricular pacing, accordingly,
in patients with ICD only (CRT-D excluded).
with and without arrhythmia. QTVINF was significantly higher in
patients with FVT/VF than in patients without FVT/VF (Table 4).
THE MEAN TREND IN LONGITUDINAL CHANGES OF INTRACARDIAC
REPOLARIZATION LABILITY
Average QTVINF in study participants with single-chamber ICD
did not change during the study period. However, average
QTVINF in patients with dual-chamber ICDs increased dur-
ing the first year after ICD implantation, but slightly decreased
thereafter (Figure 2). At the same time, no statistically signifi-
cant differences were observed in all VS, as compared to all VP
patients (Figure 3). Averaged trend in QTVINF was different in
patients with FVT/VF, as compared to patients without FVT/VF
(Figure 4).
SUBJECT-SPECIFIC CHANGES IN REPOLARIZATION LABILITY
OVER TIME
Individual patients demonstrated drastically different trends: in
some patients intracardiac QTVINF increased while in others
QTVINF decreased, stayed flat, or fluctuated over time. There were
no differences in the behavior of the subject-specific longitudinal
relationships in patients with different device type (Figure 5), or
any between groups of VS and VP patients (Figure 6). Moreover,
no differences in subject-specific QTVINF longitudinal trends
were observed in patients with FVT/VF, as compared to patients
without FVT/VF (Figure 7). Multiple cross-overs of the lines
indicated that the relative order of patients, ordered by their
baseline QTVINF, changed over time. The study population-
averaged QTVINF longitudinal relationship (Figures 2–4) was
not consistent with the subject-specific longitudinal relationship
(Figures 5–7).
We observed weak positive correlation between QTVINF at
the 1st and the 4th visits, and at the 1st and the 2nd visits
in patients with single-chamber ICD (r = 0.312; P = 0.047 and
r = 0.269; P = 0.024, respectively) and VS patients (r = 0.297;
P = 0.026 and r = 0.384; P < 0.0001, respectively), and weak
negative correlation in QTVINF at the 3rd and 4th visit (r =
−0.604; P = 0.003 in single-chamber ICD group; r = −0.426;
P = 0.021 in VS patients). Thus, in a given patient with single-
chamber ICDwho did not experience ventricular pacing, QTVINF
1 week after ICD implantation more likely positively corre-
lated with QTVINF 1.5 years after ICD implantation. If such
a patient experienced elevation of QTVINF during the 1st year
post-ICD implantation, then during the next 6 months QTVINF
was more likely decreasing (negative correlation in QTVINF
between the 3rd and the 4th visits). No significant correla-
tions between QTVINF observations at different visits in VP
patients, both with dual-chamber ICDs and CRT-D devices were
found.
ASSOCIATION BETWEEN LONGITUDINAL CHANGES IN
REPOLARIZATION LABILITY AND SUBSEQUENT FVT/VF
The mean QTVINF trend in patients without FVT/VF
demonstrated slight, but significant decrease 1.5 years after
device implantation (Figure 4A), whereas no changes in
mean QTVINF were observed in patients with FVT/VF
(Figure 4B). Patterns of the subject-specific relationships
between QTVINF and time looked alike in patients with and
without FVT/VF (Figures 7A,B). QTVINF correlations structure
in patients without FVT/VF revealed weak positive correla-
tion between the 1st and the 2nd visit (r = 0.257; P = 0.004)
and negative correlation of approximately the same strength
between the 3th and the 4th visit (r = −0.339; P = 0.040).
However, QTVINF measured at different visits in a given
patient who experienced FVT/VF during follow-up, did not
correlate.
In order to study patient-specific dynamic changes in intracar-
diac RL before FVT/VF, we plotted QTVINF before each FVT/VF
event. We used the actual time from then EGM recording to the
FVT/VF event as a continuous variable (Figure 8). Noticeably,
QTVINF distribution in patients without FVT/VF (Figure 8A)
looked similar to that in patients before FVT/VF (Figure 8B).
Trends of increasing, decreasing, and flat over time QTVINF were
observed before FVT/VF events (Figure 8C). Of note, consis-
tent pattern of increasing over time QTVINF before all FVT/VF
events was observed in some (but not all) individual patients
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Table 4 | Comparison of all-visits averaged ECG parameters in patients with and without FVT/VF during follow-up.
No FVT/VF FVT/VF P–value
(n = 525 visits) (n = 61 visits)
Heart rate(SD), bpm 73.1 (14.0) 73.4 (16.3) 0.899
QT interval(SD), s 0.479 (0.116) 0.498 (0.129) 0.278
Heart rate variance, median(IQR), ms2 45.1 (10.4–99.4) 31.9 (12.8–70.4) 0.143
QT variance, median(IQR), ms2 697.0 (147.0–1642.3) 1008 (175.0–2022.4) 0.238
QTV (SD) −0.362 (0.601) −0.186 (0.512) 0.015
FIGURE 2 | Comparison of population-averaged longitudinal trends in QTVINF in patients with (A) single-chamber ICD, (B) dual-chamber ICD, (C)
CRT-D. Scatterplot of QTVINF at each standardized study visit is shown. Lowess smoother curve shows mean trend in QTVINF over time.
FIGURE 3 | Comparison of population-averaged longitudinal trends in QTVINF in patients with (A) presenting ventricular-sensed (VS), and (B) presenting
ventricular-paced (VP) sinus rhythm. Scatterplot of QTVINF at each standardized study visit is shown. Lowess smoother curve shows mean trend in QTVINF over time.
with multiple FVT/VF events. In contrast, patients with a sin-
gle FVT/VF event tended to demonstrate rather decreasing over
time QTVINF. However, small subgroups size did not allow us to
quantify observed differences.
GEE POPULATION-AVERAGED MODEL
In multivariate GEE analysis with independent correlation struc-
ture, increasing over a time course of several months QTVINF
was significantly associated with FVT/VF event [OR 1.75 (95%CI
1.05–2.92); P = 0.031]. Thus, on average, for patients in our
study, the odds of developing FVT/VF increased by 75% for each
1 unit increase in QTVINF.
SUBJECT-SPECIFIC RANDOM INTERCEPT MODEL
Association between patient-specific dynamic changes in QTVINF
and FVT/VFwas studied in the random-effects logistic regression.
In order to determine if a specific patient with increasing QTVINF
over time experiences a greater probability of having FVT/VF,
as compared to patient with decreasing or stable QTVINF,
we ran random-effects logistic regression analysis. For a given
patient, the odds of developing FVT/VF were not associated with
increasing or decreasing QTVINF [OR 1.27; (95%CI 0.05–30.10);
P = 0.881] over time. We used 194 integration points in this
model for assurance that the likelihood is appropriately approxi-
mated, which was confirmed. In addition, we explored potential
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FIGURE 4 | Comparison of population-averaged longitudinal trends in QTVINF in patients (A) without FVT/VF, and (B) with sustained FVT/VF and
appropriate ICD shocks. Scatterplot of QTVINF at each standardized study visit is shown. Lowess smoother curve shows mean trend in QTVINF over time.
FIGURE 5 | “Spaghetti” plots of individual patient-specific longitudinal relationships between QTVINF and time for each subject with (A)
single-chamber ICD, (B) dual-chamber ICD, (C) CRT-D.
FIGURE 6 | “Spaghetti” plots of individual patient-specific longitudinal
relationships between QTVINF and time for each subject with (A)
presenting ventricular-sensed (VS), and (B) presenting
ventricular-paced (VP) sinus rhythm.
interactions and adjusted patient-specific models for the effect
of VP in preceding follow-up interval, for percentage of beats,
included in QTVI analysis by automated software, and for the
differences in follow-up time interval. Subject-specific longitu-
dinal QTVINF trend was associated neither with study outcome
(FVT/VF), nor with any other measured in this study clinical,
demographic, or ECG parameter.
DISCUSSION
Our study revealed differences in population-averaged and
patient-specific intracardiac QTVINF trends over 1.5 years
after device implantation. In patients without FVT/VF events
population-averaged QTVINF decreased after the 1st year since
ICD implantation, whereas in patients with FVT/VF events
FIGURE 7 | “Spaghetti” plots of individual patient-specific longitudinal
relationships between QTVINF and time for each subject (A) without
FVT/VF, and (B) with sustained FVT/VF and appropriate ICD shocks.
averaged QTVINF did not change. Group-averaged QTVINF
was independently associated with the odds of life-threatening
FVT/VF. On average, the odds of FVT/VF increased by 75% for
each 1 unit increase in QTVINF.In contrast, individual subject-
specific QTVINF trends in many patients differed from the mean
trend for the whole study population. Individual subject-specific
trends in intracardiac QTVINF were not associated with subse-
quent FVT/VF.
LONGITUDINAL STUDIES OF REPOLARIZATION LABILITY: MEAN TREND
VS. SUBJECT-SPECIFIC CHANGES OVER TIME
Population-averaged trends in repolarization lability and TWA
changes immediately before VT/VF have been previously studied.
The vast majority of investigators explored short-term (24–48 h)
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FIGURE 8 | (A) Variogram of QTVINF in patients without FVT/VF shows actual
time since EGM recording till censored. (B) Variogram of QTVINF in patients
with FVT/VF shows actual time since EGM recording till sustained FVT/VF
with ICD shock. (C) Line “spaghetti” plots of the longitudinal relationships
between QTVINF and actual time of FVT/VF for each patient with FVT/VF
event.
dynamic ECG changes. Shusterman et al. (2006) described an
upsurge of alternating and non-alternating RL 10min before the
onset of VT/VF in HF patients. Analysis of 24-h Holter ECG
revealed pronounced diurnal variations in QTVI (higher QT
variability in the morning and during the day, and lower QT vari-
ability during the night) in HF patients (Dobson et al., 2009).
At the same time, no significant changes in the mean QTVI
trend was detected during 12 h of ECG monitoring before the
onset of spontaneous VT/VF in the acute intensive cardiac care
unit patients (Sachdev et al., 2010). In this study population-
averaged model reflected absolute difference in QTVINF12–18
month after ICD implantation in patients with and without sub-
sequent FVT/VF (Table 4; Figure 4), and re-confirmed our previ-
ous finding of association between elevated QTVINF and VT/VF
(Tereshchenko et al., 2009).
Very few investigators studied subject-specific trends in
repolarization lability. Swerdlow and co-investigators (2011)
used subject-specific longitudinal analysis approach and showed
increased intracardiac TWA/variability immediately before
VT/VF onset in ICD patients. To the best of our knowl-
edge, our study is the first that compared patient-specific
and population-averaged longitudinal trends in intracardiac
QTVINF. Mechanistically, each individual’s longitudinal out-
come is governed by subject-specific disease dynamics over
time. Hence, each subject’s repolarization lability trajectory
neither necessarily progresses in accord with a rigid population
mean curve nor varies with bounded variation. Evidently,
some “latent” factors (not measured in this study) impacted
individual subject-specific trends in QTVINF. In patients with
structural heart disease and systolic HF multiple parame-
ters might change over time: coronary perfusion, myocardial
contractility and compliance, use of medications, affecting
repolarization (Tereshchenko et al., 2009), level of physical
activity and autonomic balance, kidney function, and many
others. Any of these unmeasured in this study factors might
play a major role in the observed subject-specific QTVINF
changes.
Recently we showed that both high and low repolarization
lability is associated with the risk of SCD in general pop-
ulation (Tereshchenko et al., 2012). In our previous analysis
of ICD-EGMs study we observed that QTVINF was decreased
after premature ventricular contraction. Paradoxically, decreased,
but not increased QTVINF was associated with VT/VF (Das
et al., 2012). While arrhythmogenesis, associated with elevated
repolarization lability is well understood (Tereshchenko and
Berger, 2011), observation of association between decreasing
QTVINF and subsequent FVT/VF is novel and prompts fur-
ther investigations. As previously shown, static QT/RR rela-
tionships (Batchvarov et al., 2002), as well as the dynamic
pattern of QT/RR hysteresis (Malik et al., 2008) is highly
patient-specific. It was even suggested that the individual
QT-RR relationship has unique “finger-print-like” properties
(Malik et al., 2008). This fact might contribute to the high
degree inter-subject variability of the dynamic QTVINF pat-
terns, observed in this study. Especially intriguing was obser-
vation of consistent increasing QTVINF trend before each
FVT/VF event in some (but not all) patients with multiple
FTV/VF events. Further mechanistic studies are needed to explore
possible mechanisms of arrhythmiogenesis, associated with
decreasing QTVINF, in order to explain subject-specific trends
fully.
EFFECT OF VENTRICULAR PACING ON REPOLARIZATION LABILITY
In this study we did not find significant differences in intracardiac
QTVINF between VS and VP patients in sinus rhythm. This obser-
vation is in concordance with our earlier study (Tereshchenko
et al., 2011) of intracardiac QTVINF in CRT patients. Of note,
we longitudinally studied only patients with consistently identical
type of the presenting rhythm across multiple visits.
Since deleterious effect of RV pacing is well known (Wilkoff
et al., 2002), we focused our analysis on evaluation of the possi-
ble longitudinal effects of amount of RV pacing on QTVINF and
study outcomes. We did not find significant differences in per-
centage of VP in patients with and without FVT/VF. Furthermore,
the percentage of VP did not influence QTVINF and was not
responsible for fluctuations of QTVINF from visit-to-visit.
CLINICAL PERSPECTIVE
In clinical practice and clinical research multiple physiolog-
ical parameters are measured repetitively and are studied
longitudinally. In the vast majority of longitudinal studies
population-averaged analysis is the only analysis applied. Very few
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longitudinal studies in electrophysiology report results of subject-
specific longitudinal analysis. However, the physicianmanages the
specific individual patient, rather than the “population-averaged”
patient, and understanding of the patient-specific trends is
extremely important for clinical decisions in the era of individ-
ualized medicine. In this study, population-averaged and subject-
specific longitudinal trend in repolarization lability demonstrated
different degree of association with subsequent FVT/VF. Further
prospective longitudinal studies of repolarization lability should
be conducted in order to understand behavior and predictors of
subject-specific longitudinal trends in repolarization lability, and
to determine its association with clinically-meaningful outcomes.
LIMITATIONS
Several limitations have to be acknowledged. First of all, the EGM
recordings were obtained not exactly at the same time of the day
during all follow-up visits. However, previous circadian study of
QT variability did not find significant differences in QT variabil-
ity during the day (Dobson et al., 2009). All EGMs were recorded
during the morning and middle-day hours (8 am–3 pm), which
minimized possible circadian effect.
Time intervals between follow up visits varied due to the
observational nature of the study. In order to overcome this lim-
itation, we standardized time intervals for longitudinal analysis.
In addition, we employed specific analytical approach, which
incorporated actual time from EGM recording to outcome.
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